T
T

Price • Tevogen Bio Holdings

TVGN

Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (“CD8+ CTLs” or “CTLs”), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.

Historical stock price chart and annual return over the past years

-90%

3 years

% Total

TVGN
-53%

3 years

Annual Return

TVGN